Search

Your search keyword '"Hacker, U. T."' showing total 30 results

Search Constraints

Start Over You searched for: Author "Hacker, U. T." Remove constraint Author: "Hacker, U. T."
30 results on '"Hacker, U. T."'

Search Results

6. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib

7. Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells

12. A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition

13. Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials

14. A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition

15. Dual targeting of Angiopoetin-2 and VEGF potentiates effective vascular normalisation without inducing empty basement membrane sleeves in xenograft tumours

17. Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

18. Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy

19. Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

20. The combination of sorafenib and everolimus in patients with solid tumors: Results of a phase I study.

21. Phase I study of regorafenib sequentially administered with either FOLFOX or FOLFIRI in patients with first-/second-line colorectal cancer.

22. Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy

25. Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectors.

26. In Vivo Synthesis of Tumor Necrosis Factor-{alpha} in Healthy Humans after Live Yellow Fever Vaccination

27. Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial.

28. Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells.

29. [Recent results of research on cancer of the colon, gastric cancer, sarcoma and bronchial carcinoma].

30. Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms.

Catalog

Books, media, physical & digital resources